CRESTOR Helps Lower Reduced Risk of Cardiovascular Disease

 

September 2, 2009

CRESTOR (rosuvastatin calcium) 20 mg tablets, as an adjunct to diet in adult patients, helps lowered LDL-C, and raise HDL-C to help slow the progression of atherosclerosis.

CRESTOR has now received regulatory approval in over 95 countries. Nearly 17 million patients have been prescribed CRESTOR worldwide. Data from clinical trials and real world use shows that the safety profile for CRESTOR is in line with other marketed statins.

For more information: www.astrazeneca-us.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.